These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 11825309

  • 1. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA.
    Expert Opin Pharmacother; 2001 Oct; 2(10):1663-70. PubMed ID: 11825309
    [Abstract] [Full Text] [Related]

  • 2. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Oct; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 3. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM, Faulds D.
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [Abstract] [Full Text] [Related]

  • 4. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ, Jarvis B.
    Drugs; 2001 Sep; 61(12):1801-33. PubMed ID: 11693467
    [Abstract] [Full Text] [Related]

  • 5. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 6. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
    Langtry HD, Wilde MI.
    Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
    [Abstract] [Full Text] [Related]

  • 7. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA.
    Am J Health Syst Pharm; 1996 Jun 15; 53(12):1401-15. PubMed ID: 8781686
    [Abstract] [Full Text] [Related]

  • 8. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Oct 15; 58(4):725-42. PubMed ID: 10551440
    [Abstract] [Full Text] [Related]

  • 9. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
    Wilde MI, McTavish D.
    Drugs; 1994 Jul 15; 48(1):91-132. PubMed ID: 7525198
    [Abstract] [Full Text] [Related]

  • 10. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ, Dunn CJ, Mallarkey G, Sharpe M.
    Drugs; 2002 Jul 15; 62(7):1091-118. PubMed ID: 11985491
    [Abstract] [Full Text] [Related]

  • 11. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 Jul 15; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 12. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Jul 15; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 13. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD, Wilde MI.
    Drugs; 1998 Sep 15; 56(3):447-86. PubMed ID: 9777317
    [Abstract] [Full Text] [Related]

  • 14. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J, Laskowiec G.
    Pol Merkur Lekarski; 1998 Jun 15; 4(24):339-41. PubMed ID: 9771021
    [Abstract] [Full Text] [Related]

  • 15. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Jun 15; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 16. Lansoprazole: a proton pump inhibitor.
    Garnett WR.
    Ann Pharmacother; 1996 Dec 15; 30(12):1425-36. PubMed ID: 8968456
    [Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA, Van Rensburg CJ, Moola S, Kotze D, Marks IN.
    Aliment Pharmacol Ther; 1998 Sep 15; 12(9):881-5. PubMed ID: 9768531
    [Abstract] [Full Text] [Related]

  • 18. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW.
    Am J Health Syst Pharm; 1999 Dec 01; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [Abstract] [Full Text] [Related]

  • 19. Age-dependent eradication of Helicobacter pylori with dual therapy.
    Treiber G, Ammon S, Klotz U.
    Aliment Pharmacol Ther; 1997 Aug 01; 11(4):711-8. PubMed ID: 9305480
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
    Katoh M, Asaka M, Kudoh M, Kagaya H, Katagiri M, Takeda H.
    J Clin Gastroenterol; 1995 Aug 01; 20 Suppl 2():S112-4. PubMed ID: 7594324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.